Clinical Trial Update: Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the safety of apixaban (BMS-562247) in Indian subjects undergoing elective total knee or total hip replacement; completed with posted re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anticoagulation-related Conditions
• Total Hip Replacement
• Total Knee Replacement

Drugs mentioned

• Apixaban (apixaban)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Anticoagulation | Phase 4 | Status: COMPLETED | Results posted: 2019-09-09